Jan. 06 CureVac ends coverage after BioNTech acquisition Alphavalue
Jan. 05 CureVac N.V.(NasdaqGM:CVAC) dropped from NASDAQ Composite Index CI
Dec. 18 BioNTech SE completed the acquisition of CureVac N.V. from dievini Hopp BioTech holding GmbH & Co. KG, KfW and others. CI
Dec. 18 BioNTech Closes CureVac Acquisition MT
Dec. 18 Biontech closes acquisition of CureVac RE
Dec. 17 CureVac N.V.(NasdaqGM:CVAC) dropped from S&P Global BMI Index CI
Dec. 03 Biontech achieves minimum condition in CureVac exchange offer RE
Dec. 02 CureVac N.V.(NasdaqGM:CVAC) dropped from NASDAQ Biotechnology Index CI
Nov. 28 CureVac N.V. - Shareholder/Analyst Call
Nov. 25 CureVac Announces Voting Results of Extraordinary General Meeting EQ
Nov. 25 CureVac N.V. Announces Management Appointments CI
Nov. 25 CureVac acquisition advances as cash runway secured to 2028 Alphavalue
Nov. 24 CureVac N.V. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
Nov. 24 CureVac Q3 Earnings, Revenue Fall MT
Nov. 24 Earnings Flash (CVAC) CureVac Posts Q3 Revenue 54.1M Euros MT
Nov. 24 Earnings Flash (CVAC) CureVac Posts Q3 EPS 1.21 Euros MT
Nov. 24 CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2025 and Provides Business Updates EQ
25-10-24 CureVac N : Convening Notice EGM 25 November 2025 PU
25-10-24 CureVac N : Proxy Card EGM 25 November 2025 PU
25-10-24 CureVac N : Merger Proposal PU
25-10-24 CureVac N : Explanatory Notes to the Merger Proposal PU
25-10-22 BioNTech Initiates $1.25 Billion Public Exchange Offer for CureVac MT
25-10-22 Biontech commences public exchange offer for all outstanding shares of CureVac N.V. RE
25-08-18 CureVac: Despite weak Q2, acquisition remains on track Alphavalue
25-08-15 CureVac N.V. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
No results for this search